GlassScriptPhysician profile
Steven M Kent
NPI 1982644035
$2,272.47
in general payments reported to CMS, 2019-2025
24 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $207 · 2021: $84.34 · 2022: $156 · 2023: $893 · 2024: $97.82 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $507.67 | 2023 | Watchman Access System |
| Abbott Laboratories | $248.84 | 2019-2025 | Mitraclip, Cardiomems, Amplatzer Amulet |
| Actelion Pharmaceuticals US, INC. | $224.78 | 2019-2022 | |
| Cleerly, INC. | $175.00 | 2025 | Cleerly Ischemia, Cleerly Labs |
| E.R. Squibb & Sons, L.L.C. | $168.15 | 2019-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $141.47 | 2020-2021 | |
| Organogenesis INC. | $117.19 | 2023 | Puraply |
| Alnylam Pharmaceuticals INC. | $113.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $97.50 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.42 | 2021-2024 | Lifevest |
| Pfizer INC. | $86.35 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $76.88 | 2019-2024 | Xarelto |
| Amgen INC. | $31.31 | 2021-2025 | Repatha |
| Daiichi Sankyo INC. | $27.26 | 2023 | Injectafer |
| Heartflow, INC. | $23.33 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $22.42 | 2019 | |
| Irhythm Technologies, INC. | $21.43 | 2024 | Zio Xt Patch, Zio Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $18.05 | 2025 | |
| Edwards Lifesciences Corporation | $16.42 | 2022 | |
| Novo Nordisk INC | $16.04 | 2021 | |
| Medtronic, INC. | $15.04 | 2023 | Linq II |
| Braemar Manufacturing, LLC | $13.74 | 2019 | |
| Livanova USA, INC. | $11.89 | 2019 | |
| B. Braun Interventional Systems INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.